Enochian Biosciences, Inc.

Enochian Biosciences, Inc.verified

ENOB

Price:

$0.7125

Market Cap:

$145.94M

Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-11, a preventative HIV vaccine; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a coopting HBV polymerase. Its pipeline development products comprise ENOB-DC-11 off the shelf DC vaccine for multiple solid tumors; and ENOB-DC-21, a non-specific vaccine for intraturmoral injection. Enochian Biosciences, In...[Read more]

Industry

Biotechnology

IPO Date

2018-02-07

Stock Exchange

NASDAQ

Ticker

ENOB

The Enterprise Value as of December 2024 (TTM) for Enochian Biosciences, Inc. (ENOB) is 149.54M

According to Enochian Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 149.54M. This represents a change of -23.27% compared to the average of 194.90M of the last 4 quarters.

Enochian Biosciences, Inc. (ENOB) Historical Enterprise Value (quarterly & annually)

How has ENOB Enterprise Value performed in the past?

The mean historical Enterprise Value of Enochian Biosciences, Inc. over the last ten years is 108.42M. The current 149.54M Enterprise Value has changed 13.69% with respect to the historical average. Over the past ten years (40 quarters), ENOB's Enterprise Value was at its highest in in the March 2022 quarter at 430.44M. The Enterprise Value was at its lowest in in the June 2018 quarter at -15600865.00.

Quarterly (TTM)
Annual

Average

108.42M

Median

84.87M

Minimum

35.62M

Maximum

221.07M

Enochian Biosciences, Inc. (ENOB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Enochian Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 331.51%

Maximum Annual Enterprise Value = 221.07M

Minimum Annual Increase = -64.10%

Minimum Annual Enterprise Value = 35.62M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024153.71M331.51%
202335.62M-64.10%
202299.22M-55.12%
2021221.07M13.99%
2020193.94M24.96%
2019155.20M171.13%
201857.24M-18.83%
201770.52M25.20%
201656.33M36.24%
201441.34M39.87%

Enochian Biosciences, Inc. (ENOB) Average Enterprise Value

How has ENOB Enterprise Value performed in the past?

The current Enterprise Value of Enochian Biosciences, Inc. (ENOB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

96.19M

5-year avg

140.71M

10-year avg

108.42M

Enochian Biosciences, Inc. (ENOB) Enterprise Value vs. Peers

How is ENOB’s Enterprise Value compared to its peers?

Enochian Biosciences, Inc.’s Enterprise Value is greater than Aerovate Therapeutics, Inc. (44.29M), greater than Adagene Inc. (13.88M), less than Acrivon Therapeutics, Inc. Common Stock (153.64M), less than Rezolute, Inc. (244.24M), greater than AN2 Therapeutics, Inc. (6.98M), greater than Molecular Partners AG (107.67M), less than Mineralys Therapeutics, Inc. (522.59M), less than Pharvaris N.V. (666.92M), greater than PepGen Inc. (104.85M), greater than Anebulo Pharmaceuticals, Inc. (38.79M), greater than PMV Pharmaceuticals, Inc. (40.27M), greater than MediciNova, Inc. (58.71M), greater than Champions Oncology, Inc. (116.65M), greater than Cyteir Therapeutics, Inc. (-20511738.00), less than Eliem Therapeutics, Inc. (0),

Build a custom stock screener for Enochian Biosciences, Inc. (ENOB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enochian Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Enochian Biosciences, Inc. (ENOB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Enochian Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Enochian Biosciences, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Enochian Biosciences, Inc. (ENOB)?

What is the 3-year average Enterprise Value for Enochian Biosciences, Inc. (ENOB)?

What is the 5-year average Enterprise Value for Enochian Biosciences, Inc. (ENOB)?

How does the current Enterprise Value for Enochian Biosciences, Inc. (ENOB) compare to its historical average?